First Trust Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $331M | Buy |
1,519,986
+183,488
| +14% | +$40.7M | 0.24% | 108 |
|
|
2025
Q4 | $305M | Buy |
1,336,498
+841,947
| +170% | +$192M | 0.22% | 104 |
|
|
2025
Q3 | $115M | Sell |
494,551
-1,007,670
| -67% | -$205M | 0.09% | 282 |
|
|
2025
Q2 | $279M | Sell |
1,502,221
-1,155,532
| -43% | -$215M | 0.22% | 98 |
|
|
2025
Q1 | $557M | Sell |
2,657,753
-1,097,253
| -29% | -$213M | 0.49% | 26 |
|
|
2024
Q4 | $667M | Buy |
3,755,006
+678,525
| +22% | +$125M | 0.59% | 18 |
|
|
2024
Q3 | $608M | Sell |
3,076,481
-117,665
| -4% | -$22M | 0.58% | 19 |
|
|
2024
Q2 | $548M | Sell |
3,194,146
-154,686
| -5% | -$25.6M | 0.56% | 21 |
|
|
2024
Q1 | $610M | Sell |
3,348,832
-523,620
| -14% | -$90.2M | 0.62% | 16 |
|
|
2023
Q4 | $600M | Sell |
3,872,452
-213,358
| -5% | -$31.1M | 0.65% | 13 |
|
|
2023
Q3 | $609M | Sell |
4,085,810
-376,411
| -8% | -$55.3M | 0.72% | 12 |
|
|
2023
Q2 | $601M | Sell |
4,462,221
-117,224
| -3% | -$17.2M | 0.68% | 11 |
|
|
2023
Q1 | $730M | Buy |
4,579,445
+777,433
| +20% | +$119M | 0.84% | 3 |
|
|
2022
Q4 | $614M | Buy |
3,802,012
+686,191
| +22% | +$105M | 0.73% | 7 |
|
|
2022
Q3 | $418M | Buy |
3,115,821
+117,912
| +4% | +$16.9M | 0.54% | 15 |
|
|
2022
Q2 | $459M | Buy |
2,997,909
+1,465,720
| +96% | +$224M | 0.57% | 11 |
|
|
2022
Q1 | $248M | Buy |
1,532,189
+530,127
| +53% | +$77M | 0.25% | 99 |
|
|
2021
Q4 | $136M | Sell |
1,002,062
-104,706
| -9% | -$12.4M | 0.13% | 193 |
|
|
2021
Q3 | $119M | Sell |
1,106,768
-80,730
| -7% | -$9.22M | 0.13% | 204 |
|
|
2021
Q2 | $134M | Sell |
1,187,498
-254,581
| -18% | -$28.7M | 0.14% | 179 |
|
|
2021
Q1 | $156M | Buy |
1,442,079
+373,635
| +35% | +$40M | 0.19% | 136 |
|
|
2020
Q4 | $114M | Sell |
1,068,444
-282,758
| -21% | -$27.2M | 0.15% | 169 |
|
|
2020
Q3 | $118M | Sell |
1,351,202
-421,306
| -24% | -$39.7M | 0.19% | 131 |
|
|
2020
Q2 | $174M | Buy |
1,772,508
+699,303
| +65% | +$61.6M | 0.3% | 64 |
|
|
2020
Q1 | $81.8M | Sell |
1,073,205
-6,704
| -0.6% | -$571K | 0.19% | 133 |
|
|
2019
Q4 | $95.6M | Sell |
1,079,909
-120,045
| -10% | -$9.97M | 0.16% | 139 |
|
|
2019
Q3 | $90.9M | Buy |
1,199,954
+158,805
| +15% | +$10.9M | 0.17% | 141 |
|
|
2019
Q2 | $75.7M | Sell |
1,041,149
-330,828
| -24% | -$26M | 0.14% | 188 |
|
|
2019
Q1 | $111M | Buy |
1,371,977
+670,186
| +95% | +$54.8M | 0.22% | 101 |
|
|
2018
Q4 | $64.7M | Sell |
701,791
-490,174
| -41% | -$43.1M | 0.15% | 153 |
|
|
2018
Q3 | $113M | Sell |
1,191,965
-150,164
| -11% | -$14.2M | 0.21% | 93 |
|
|
2018
Q2 | $124M | Buy |
1,342,129
+346,459
| +35% | +$33.8M | 0.26% | 67 |
|
|
2018
Q1 | $94.2M | Sell |
995,670
-217,183
| -18% | -$23.9M | 0.22% | 88 |
|
|
2017
Q4 | $117M | Sell |
1,212,853
-85,957
| -7% | -$8.1M | 0.28% | 59 |
|
|
2017
Q3 | $115M | Sell |
1,298,810
-111,574
| -8% | -$8.49M | 0.3% | 51 |
|
|
2017
Q2 | $102M | Buy |
1,410,384
+42,704
| +3% | +$2.87M | 0.27% | 65 |
|
|
2017
Q1 | $89.1M | Buy |
1,367,680
+144,231
| +12% | +$9.07M | 0.25% | 67 |
|
|
2016
Q4 | $76.6M | Buy |
1,223,449
+85,965
| +8% | +$5.25M | 0.23% | 64 |
|
|
2016
Q3 | $71.7M | Buy |
1,137,484
+67,841
| +6% | +$4.39M | 0.21% | 83 |
|
|
2016
Q2 | $66.2M | Sell |
1,069,643
-46,720
| -4% | -$2.85M | 0.21% | 80 |
|
|
2016
Q1 | $63.8M | Sell |
1,116,363
-456,668
| -29% | -$25.5M | 0.2% | 90 |
|
|
2015
Q4 | $93.2M | Sell |
1,573,031
-411,485
| -21% | -$23.7M | 0.24% | 86 |
|
|
2015
Q3 | $108M | Buy |
1,984,516
+730,082
| +58% | +$47.5M | 0.31% | 60 |
|
|
2015
Q2 | $84.3M | Sell |
1,254,434
-227,104
| -15% | -$14.8M | 0.22% | 96 |
|
|
2015
Q1 | $86.7M | Buy |
1,481,538
+143,033
| +11% | +$8.64M | 0.25% | 83 |
|
|
2014
Q4 | $87.6M | Sell |
1,338,505
-5,331
| -0.4% | -$336K | 0.3% | 60 |
|
|
2014
Q3 | $77.6M | Buy |
1,343,836
+474,664
| +55% | +$26.4M | 0.31% | 48 |
|
|
2014
Q2 | $49.1M | Sell |
869,172
-654,034
| -43% | -$34.3M | 0.2% | 91 |
|
|
2014
Q1 | $78.3M | Buy |
1,523,206
+813,225
| +115% | +$41.1M | 0.34% | 33 |
|
|
2013
Q4 | $37.5M | Buy |
709,981
+296,823
| +72% | +$14.6M | 0.18% | 108 |
|
|
2013
Q3 | $18.5M | Buy |
413,158
+229,133
| +125% | +$10.2M | 0.1% | 273 |
|
|
2013
Q2 | $7.61M | Buy |
+184,025
| New | +$8.05M | 0.05% | 556 |
|
Other funds holding ABBV
VCM
VPM
First Trust Advisors's ABBV Position: Q1 2026 in Review
First Trust Advisors increased its AbbVie (ABBV) stake by 14% in Q1 2026, buying an estimated $40.7M and bringing the position to 1,519,986 shares worth $331M. The position accounts for 0.24% of the portfolio, ranked #108.
First Trust Advisors first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $730M in Q1 2023. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- First Trust Advisors held 1,519,986 shares of AbbVie worth $331M as of Q1 2026.
- First Trust Advisors bought 183,488 AbbVie shares in Q1 2026, an estimated $40.7M.
- AbbVie made up 0.24% of First Trust Advisors's portfolio in Q1 2026, its #108 holding.
- First Trust Advisors first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- First Trust Advisors's AbbVie position peaked at $730M in Q1 2023.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.